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Abstract
Introduction: the reaction states or leprosy reactions are periods of 
acute inflammation in the course of a chronic illness, the main cause 
of damage to the nerves and disabilities caused by leprosy. They are 
divided into three types: reversal reaction, erythema nodosum lepro-
sum and isolated neuritis. 
Objective: To describe the clinical characteristics of cases of leprosy 
reactions in a city of high backlands of Paraiba. 
Method: Utilized a structured and individual questionnaire applied 
in the homes of patients and former patients of Hansen’s disease 
who developed leprosy reactions, registered in the three Family Health 
Units with more cases of leprosy in the city of Cajazeiras – PB. 
Results: Among the 22 participants, most were male, aged over 61 
years old and incomplete primary education. Regarding the classifica-
tion of leprosy, 90.9% were multibacillary and 77.2% of the blacke-
ning clinical form. When evaluated the type of reaction, 68.2% were 
considered cases of RR or type 1 reaction, 45.5% developed reactions 
during treatment and 40.9% after discharge by cure. 
Conclusion: The study demonstrates the need for qualification of 
the professionals in the primary health care to a greater and better 
monitoring of these cases by the Family Health Strategy, so much so 
that the leprosy reactions are diagnosed early during treatment and 
after discharge, as mainly for carrying out monitoring conducts of 
Features of Clinical and Epidemiological Reactions of 
Leprosy Cases in a City of the High Backlands of Paraíba 
 ORIGINAL 
1  Bachelor of Nursing. Specialist in 
Intensive Care Unit, University Cândido 
Mendes, Brazil. 
2  Master Student of Collective Health, 
Catholic University of Santos, Brazil.
3  Bachelor of Nursing, Federal University 
of Campina Grande, Brazil. 
4  Bachelor of Nursing, Specialist in 
Oncology, Integrated College of Patos, 
Brazil. 
5  Specialist in Infectology, University of 
Pernambuco, Brazil.
6  Specialist in Cardiology. Master Student 
of Nursing, University of Pernambuco/
State University of Paraíba, Brazil. 
7  Teacher of Technical School of Health 
of Cajazeiras, Federal University of 
Campina Grande, Brazil. 
8  Bachelor of Nursing, Regional 
University of Cariri. Grupo de Pesquisa, 
GPCLIN, Brazil. 
9  Bachelor of Nursing, University of 
Fortaleza, Brazil.
10  Nutricionist, Multiprofessional 
Assistant Resident in Transplant, 
Federal University of Ceará, Brazil. 
Contact information:
Bárbara Letícia de Queiroz Xavier.
 barbaraleticia.qx@hotmail.com
Bárbara Letícia de Queiroz Xavier1, Maria Mônica Paulino do Nascimento2, Brenda dos Santos Teixeira3, 
Anthonio Alisancharles Batista de Almeida3, Jéssica Barreto Pereira4, Andressa Pedroza Pereira5,
 Hirla Vanessa Soares de Araújo6, Rayanne Rilka Pereira da Silva3, Maria Soraya Pereira Franco7, 
Andressa Séfora Queiroga de Sousa3, Maria Tibéria da Silva Carolino3, Riani Joyce Neves Nóbrega8, 
Priscila Nunes Costa Travassos9, Ana Carolina Cavalcante Viana10
InternatIonal archIves of MedIcIne 
sectIon: InfectIous dIseases
ISSN: 1755-7682
2016
Vol. 9 No. 326
doi: 10.3823/2197
This article is available at: www.intarchmed.com and www.medbrary.com 2
Introduction
Leprosy is characterized as a chronic infectious di-
sease potentially incapacitating, with the bacillus 
Mycobacterium leprae as is an etiologic agent, cau-
sing lesions on the skin and peripheral nerves of the 
eyes, upper and lower limbs. It has different clinical 
forms that are determined by cellular immune res-
ponse levels of this bacterium, being classified as 
indeterminate, tuberculoid, dimorphic and Virchow 
[1].
Even with all the efforts and progress in the in-
tegration of leprosy control in the health care area, 
this disease is still considered a public health pro-
blem [2]. According to Lastória and Abreu [3], Brazil 
is the only country not reaching the goal of elimina-
ting the disease, which is defined by the prevalence 
of less than 1 case/10,000. In 2011, 33,955 new 
cases were detected, with the prevalence rate of 
1.54/10,000.
After India, Brazil is the second country in the 
world with the highest number of leprosy cases. [4] 
Considered a public health problem, the Ministry of 
Health (MOH) is committed to eliminating leprosy by 
2015 that is to achieve less than 1 case per 10,000 
inhabitants. For it, it launched the Integrated Stra-
tegic Action Plan for the Elimination of Leprosy and 
other diseases, diseases that are important to pu-
blic health and increasing early detection and cure 
of diagnosed cases. Although Brazil records conti-
nuous decrease in the prevalence rate and detection 
of new cases of leprosy, the North, Northeast and 
Midwest are considered more endemic, with areas 
of major maintenance of transmission [5-7].
The reaction conditions or leprosy reactions are 
characterized by immune system reactions to the 
patient´s bacillus [8]. These reactions are periods of 
acute inflammation in the course of a chronic disea-
se, a characteristic of leprosy and can affect the ner-
ves of the patient [9]. Individuals with leprosy can 
be surprised by pictures or reaction States, events in 
the course of the disease, which is present in about 
10-50% of cases, occurring mainly in multibacillary 
ways. They are important risk factors for leprosy 
retreatment, as well as responsible for the abandon-
ment of treatment and disability [10].
During the first months of chemotherapy 
treatment of leprosy, reaction states occur but may 
occur before or even after curing the patient. These 
reaction conditions are the major cause of nerve 
damage and disability caused by leprosy [8]. Accor-
ding to Antonio et al. [11], the leprosy reactions are 
divided into three clinical forms: reversal reaction 
(RR), erythema nodosum (ENL) and isolated neu-
ritis (NEU). The RR is a cellular immune reaction, 
caused by a heightened response of the host to 
antigens released by bacterial destruction. ENL in-
volves humoral immunity linked to the destruction 
of bacilli with antigen stimulation and exposure to 
antibody production. The NEU is characterized by 
inflammation of peripheral nerve trunks, with alte-
ration of sensory, motor and autonomic functions, 
triggering disabilities.
The interest in the topic arose during the under-
graduate course in Nursing, specifically in classes of 
Clinical Nursing II and during the Supervised Scho-
larship I in a Basic Health Unit (BHU) in the city of 
Cajazeiras - PB. From the experiences while moni-
toring the subject, it was also possible to observe 
the existence of leprosy cases with leprosy reactions 
and the association with the emergence of physical 
neural damage and prevention of physical disabilities, avoiding them 
from installing deformities that impair daily activities and the interac-
tion of these people in society.
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disabilities, as well as how these diseases interfere 
with activities of daily living of these people and 
even the belief that the disease has healed, displa-
ying a big problem for the life of these patients.
This work is justified by the lack of studies on the 
epidemiological and clinical characteristics of cases 
of leprosy reactions and to recognize the importan-
ce of this knowledge for the development of public 
policies and strategies improving the quality of mo-
nitoring and these individuals for health services, 
especially by the Family Health Units. It is observed 
that there is still insufficient monitoring of these 
cases by the Family Health Units (FHU), both during 
and after treatment with multidrug therapy (MDT).
The study results may also contribute to the aware-
ness of health professionals, including nurses, aimed 
at more effective monitoring of reaction states and 
neural functions, which demonstrate recognition of 
the importance of prevention from physical actions 
improving the quality of life of people. Thus, this 
study aims to describe the clinical characteristics of 
cases of leprosy reactions in a city of high backlands 
of Paraíba.
Method
This is a descriptive and exploratory study with a 
quantitative approach, conducted with patients and 
former patients registered with leprosy in the three 
FHUs that had the highest number of reported ca-
ses of the disease in the city of Cajazeiras, which 
has high incidence and prevalence of cases of the 
disease in the state of Paraíba.
The target population was the leprosy cases re-
ported between 2010 and 2014 in the Information 
System of Municipal Health Secretary of Notifiable 
Diseases regarding the three selected FHUs, corres-
ponding to a total of 99 cases. The sample selection 
was intentionally being comprised of carriers and 
former leprosy patients who developed or were de-
veloping leprosy reactions during the study period, 
totaling 22 participants.
The defined inclusion criteria were: aged 18 years 
old, using MDT or have completed treatment for 
leprosy and have leprosy reactions. The study ex-
cluded individuals who, although they have been 
recorded as a case of leprosy reaction.
Data collection was carried out at participants´ 
home, by an interview with a structured question-
naire containing demographic data and information 
on the clinical characteristics of leprosy and leprosy 
reactions. Data were compiled in a spreadsheet de-
veloped by Microsoft Excel and analyzed by simple 
descriptive statistics, using frequency and percen-
tage.
This study design was approved by the Research 
Ethics Committee of the Teacher Training Center/
Federal University of Campina Grande under CAAE 
Nº 44860115.8.0000.5575 and opinion 1,171,900.
Results 
The study included 22 participants, and the highest 
frequency of leprosy reactions occurred among ma-
les (68.2%) older than 61 years old (40.9%), married 
(59.1%), skin color/mulatto (54.5%), with incomple-
te primary education (45.4%), retired (40.9%), Ro-
man Catholics (72.7%) and had a family income of 
up to one minimum wage (95.5%).
Regarding the characteristics of leprosy, 90.9% of 
the sample had a multibacillary operational classifi-
cation, Borderline as the most prevalent clinical form 
(77.2%), with negative sputum smears at diagnosis 
(45.5%). About leprosy reactions, 68.2% were type 
1, 45.5% occurred during treatment, and 31.8% 
had no knowledge of the possibility of developing 
such reactions, as shown in Table 1.
Table 1.  Distribution of the characteristics of leprosy 
and leprosy reactions. Cajazeiras - PB, 2015.
Variables n %
Operational classification
Paucibacillary 2 9.1
Multibacillary 20 90.9
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Table 2 shows the distribution of cases of leprosy 
reactions according to nerve damage and eviden-
ced clinical signs. The most affected nerves were 
the median (40.9%) and ulnar (36.4%). Regarding 
clinical signs, there was a higher frequency of pain 
or loss of sensation in the skin and nerves (77.3%), 
further reduction of visual acuity (63.6%) and pain 
and redness (59.1%) in the eye, and swelling feet 
(59.1%).
Regarding the development of physical disabilities 
caused by leprosy reactions, as observed in Table 3 
was more prevalent on the level two (54.5%), and 
its appearance occurred during and after treatment 
(27.3% for both).
Table 2.  Distribution of cases of leprosy reactions ac-
cording to nerve damage and clinical signs. 
Cajazeiras-PB, 2015.
Variables n %
Damaged nerves*
Ulnar 8 36.4
Median 9 40.9
Radial 4 18.2
Fibular 3 13.6
Tibial 4 18.2
Table 3.  Distribution of cases of leprosy reactions 
according to the development of physical 
disabilities. Cajazeiras - PB, 2015.
Variables n %
Level of current disability
Zero 7 31.8
One 2 9.1
Two 12 54.5
Not informed 1 4.6
Emergence of physical disabilities*
Before treatment 2 9.1
During treatment 6 27.3
After treatment 6 27.3
Not informed 8 36.4
Source: Direct research, 2015.
* There was the possibility of more than one answer.
Variables n %
Clinical form
Indeterminate 1 4.6
Tuberculoid 1 4.6
Bordeline 17 77.2
Virchow 3 13.6
Smear diagnosis
Positive 7 31.8
Negative 10 45.5
Not informed 5 22.7
Type of leprosy reaction*
Type 1 15 68.2
Type 2 7 31.8
Type 1 and 2 2 9.1
Moment of appearance of leprosy reaction
Before treatment 3 13.6
During treatment 10 45.5
After treatment 9 40.9
Knowledge about leprosy reaction
Yes 15 68.2
No 7 31.8
Source: Direct research, 2015. 
*There was the possibility of more than one answer
Variables n %
Clinical signs of the skin and nerves *
Inflamed lesions 11 50
Subcutaneous nodules 8 36.4
Pain or loss of sensation 17 77.3
New loss of sensation 10 45.5
New muscle weakness 9 40.9
Clinical signs in the eyes *
Pain and redness 13 59.1
New decreased visual acuity 14 63.6
New muscle weakness in the closure 
of the eyelids
3 13.6
Clinical signs in the upper limbs
Swelling hand (s) 6 27.3
Not showed 16 72.7
Clinical signs in the lower limbs
Swelling feet 13 59.1
Not showed 9 40.9
Source: Direct research, 2015.
* There was the possibility of more than one answer.
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Discussion
The estimated sample consisted of 25 participants, 
but due to address changes, it was not possible 
to apply the questionnaire to 3 of them. The final 
study sample was 22 participants between case pa-
tients and former patients of leprosy, with a history 
of reactions leprosy. Of these participants, 4 had 
and 18 former patients.
There were many difficulties in the development 
of research, from obtaining information on the po-
pulation, especially the location of their homes of 
the participants during the data collection and even 
the very identity of these cases on the Notifiable 
Diseases Information System (SINAN). These difficul-
ties were expected to start a field research, becau-
se it was possible to observe the non inadequate 
filling or to fill the gaps related to leprosy reactions 
in SINAN notification form, which may indicate a 
deficiency in the monitoring of these cases by the 
health services and low concern monitoring, and 
difficult to do further research with the same infor-
mation system.
Furthermore, another difficulty was not aware of 
the disease by the respondents, necessary to clarify 
some doubts in the course of the interview, because 
most people do not know or understand what is a 
leprosy reaction until even some health professio-
nals have demonstrated this difficulty.
As the operational classification, the multibacillary 
was 90.9% of cases. This finding was in various lite-
rature studied, confirming a direct connection with 
the development of leprosy reactions at any time 
during the treatment, or for some years after the 
treatment has been completed. For Silva and Griep 
[12], this clinical manifestation is the most frequent 
reactions during and after curing.
A higher rate of MB patients was also found in 
the study by Araújo et al. [1]. The high percentage 
of multibacillary demonstrates a delay in diagnosis, 
allowing for questioning the lack of case detection 
in the initial phases by the basic health network, 
reinforcing the importance of training for health 
workers [13].
People who develop multibacillary who had been 
presented nerve damage at diagnosis should be fo-
llowed more closely by the nursing staff to check 
the rise of new signs that require treatment because 
these people are more likely with about 65% deve-
loping new neuronal injury [14].
By analyzing the clinical form of the participants, 
the most prevalent was the dimorphic 77.2%, fo-
llowed by Virchow with 13.6%. This result may de-
monstrate that the diagnosis of leprosy was per-
formed later, increasing the likelihood of disease 
transmission, besides being the clinical forms ex-
pected to develop neural complications and physical 
disabilities in the patient.
These findings are also found in the research of 
Neves et al. [15] held in Palmas/TO during 2005 to 
2010 with 1362 cases of leprosy reported in the 
dimorphic clinical form appears with the percentage 
of 48.6%, followed by 21.3% of Virchow, as well as 
the study of Cooke et al. [16]. However, the work 
of Rodini et al. [17] diverges from this, because the 
clinical form that got most often was Virchow with 
35%.
Regarding the result of sputum smear micros-
copy, 45.5% of the results were negative, when 
observed in this study that the highest percentage 
of patients were multibacillary (MB) (17 dimorphic 
and 3 Virchow). Since as dimorphic, it is expected 
that the smear is negative or positive, necessarily 
positive just being in Virchow. Corroborating stu-
dies of Carneiro et al. [13] evaluating the endemic 
situation of leprosy in a city in the interior of Rio 
Grande do Sul, the negative sputum smears were 
performed in the highest percentage of 39.5% of 
the cases evaluated.
Of all patients with leprosy reactions in this 
study, 68.2% were type 1 reverse reaction, and 
31.8% of type 2 erythema nodosum leprosy. 
People with leprosy MB can develop both reac-
tions of type 1 and type 2, which in this study 
is consistent with the literature by presenting the 
high percentage of patients with both types of 
reaction.
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According to Teixeira, Silveira and França [10] in 
their study, the highest percentage of cases was 
type 1 reaction, then type 2 and finally the mixed 
type. In studies conducted by Nery [18] and Rego 
[19], the highest percentage was in patients with 
ENL, since both studies were composed of multi-
bacillary individuals, and this type of reaction oc-
curs more often in dimorphic and Virchow forms, 
diverging data from this research that the highest 
percentages were of type 1 reaction.
The largest number of leprosy reactions emer-
ged during treatment with 45.5% and 40.9% after 
treatment. Monitoring the reaction episode should 
be part of the routine health services network, as 
this is a measure to prevent the evolution of dete-
rioration of neural function, and reduce the cost of 
treatment and improve the quality of life of patients.
This is similar to the study of Monteiro et al. [2] 
where the findings showed an association between 
the occurrence of leprosy reactions during and af-
ter treatment of multidrug therapy. In the study by 
Souza et al. [20], among patients registered at the 
dermatology and Leprosy Service of Antonio Car-
los Pereira Unit in Juiz de Fora municipality, 52.5% 
had leprosy reactions during or after MDT multidrug 
therapy.
It is extremely important to understand the corre-
lation between the clinical forms and reactive states, 
especially when these states occur after discharge 
for healing and can be mistaken for relapse [21]. For 
Teixeira, Silveira and França [10], when the reaction 
pictures occur late, after the drug discharge, the 
diagnosis is more difficult because of the need for 
differentiation of recurrence.
The presence of leprosy reactions after the 
treatment makes them more prone to developing 
physical deformities individuals because they are al-
ready off the record and are no longer followed. 
This can lead patients to disregard signs and symp-
toms as possible complications, making belatedly 
seek health services. Therefore, the post-discharge 
monitoring should be part of routine health servi-
ces. [22]
Because of deformities, people affected by le-
prosy may suffer a loss in their ability to work and, 
consequently, the self-sufficiency and family´s, ge-
nerating impact of psychological, social and physical 
aspects [23, 10].
Although 68.2% of participants have claimed to 
have a knowledge of the leprosy reaction, they are 
still confused with leprosy believing its reappearan-
ce. This fact makes clear the need for more effective 
strategies for the dissemination of information diffe-
rence between the two conditions and telling the 
population that leprosy rarely relapse when treated 
properly.
It was found in this study that the dropout rate 
in the treatment was 68.2%, accounting for 15 of a 
total of 22 of the patients, thus consider it too high. 
During the data collection, it was observed that the 
abandonment was related to disbelief in curing the 
disease with the completion of MDT, change in skin 
color and the worsening of symptoms when leprosy 
reactions emerged.
Study to assess the disability prevention in leprosy 
supported in a self-care manual, 29 of the 55 pa-
tients studied did not join the full intervention of 
multidrug therapy. This non-adherence can be jus-
tified by the socioeconomic and cultural conditions, 
dependence on transport, low expectations regar-
ding the non-drug treatment and because it is a 
chronic and stigmatizing disease [17].
Patients with leprosy reactions can develop va-
ried clinical and various types of neural damage. 
In this study, it was observed the manifestation of 
clinical signs in every nerve, usually associated with 
pain complaints. For Almeida et al. [24], injury or 
impairment of the peroneal and tibial nerves carry 
sensory loss across the foot. Conti, Almeida and Al-
meida [25] cite in their study that the nerves usually 
affected are mixed, that is, have sensory, motor and 
autonomic fibers and changes happen in all these 
aspects.
In the skin, the participants had inflamed lesions 
and subcutaneous nodules. In the eyes, there was 
uncomfortable regarding eyesight and muscle 
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strength. There are few studies that address the 
descriptive aspect of the occurrence of nerve 
damage in leprosy reactions. Another limitation of 
the study was self-reported because as in most cases 
the questionnaire was applied during the treatment 
of reaction episode, the signs and symptoms have 
been reported based on previous episodes of stories, 
which can compromise the reliability of the results.
When evaluated the clinical signs in the limbs, 
it was found that 59.1% of cases have developed 
swollen foot. It is observed a lower proportion in 
the development of clinical signs in the hands, to be 
a region of early perception and its easy application 
of self-care measures, reducing the frequency of 
disabilities.
These findings are consistent with those found 
by Carvalho and Alvarez [26], the authors found 
a high frequency of disability in the feet, isolated, 
compared with the results found in the hands. To 
Araújo et al. [1], the greater presence and increased 
the frequency of physical disabilities, especially in 
the feet, may have been influenced by carelessness 
in the guidelines related to self-care.
This leads to the question about the development 
of actions that could have been done to prevent this 
scenario. For prevention of disabilities in the house-
hold level, it is necessary for addition to educatio-
nal interventions, a close monitoring of the neural 
function of these patients, both during treatment 
and after discharge. Croft [27] believes that the de-
gree of disability is directly related to the time of 
disease progression.
According to the “Enhanced Global Strategy for 
Further Reducing the Burden of Leprosy: 2011-2015”, 
the current global target for reducing the burden 
of leprosy defines the reduction of new cases rate 
diagnosed with grade 2 disabilities per 100 000 
inhabitants in at least 35% by the end of 2015 [28].
It is observed that the time to emergence of 
physical disabilities was the same during and after 
treatment, with 27.3% being lower frequency befo-
re treatment. This percentage may be linked to non-
clinical monitoring of patients during the treatment 
period or after leaving an active record of leprosy 
cases. These data agree with the findings in the 
surveys conducted by Schiapati [29] and Araújo et 
al. [1], where it was found a lower rate of physical 
disabilities at the beginning of treatment.
Approximately 23% of patients with leprosy de-
velop disability after discharge [30]. For Goulart, 
Penna and Cunha [31] evaluation and monitoring 
of the state in which patients are is necessary to 
identify early neural complications and disabilities, 
essential for the preservation of the structure and 
function of the peripheral nerve.
A higher percentage was related to a variable 
not informed, with 36.7%. However, it does not 
mean that these patients developed no neural thic-
kening or pain during treatment. It may indicate a 
failure in the dissemination of information to the 
patient, such as lack of evaluation in the disability 
record.
Health services should concentrate a greater num-
ber of activities for qualified monitoring of cases of 
leprosy, not only at diagnosis and during treatment, 
but also after discharge of multidrug therapy, as 
this is the time when the commitment is the neural 
function, being a determining factor in the develo-
pment of disability or physical deformity [27].
Conclusion
The results show that leprosy reactions occur more 
often in multibacillary during or after treatment with 
MDT, corroborating the literature. This represents a 
major challenge for leprosy programs at all health 
care levels, ideal for promoting more effective stra-
tegies for the diagnosis, control and treatment of 
leprosy reactions.
The findings reinforce the need for clinical mo-
nitoring by the family health team after the end of 
treatment, for at least six months to seven years 
after discharge, since in some patients the neural 
impairment may occur slowly and silently.
On neural damage, it was observed that the de-
gree of disability 2 was the most noticeable among 
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these individuals, considering that this disabling po-
tential causes physical injury, impairment in social 
participation, as well as psychological damage and 
difficulty in activities of the everyday life of these 
people. However, it can be seen that they received 
instructions for self-care and prevention of disabili-
ties, which raises the question of the assimilation of 
information may have been hampered by the low 
level of education.
It is understood that the data presented here can 
provide subsidies for the development of educatio-
nal strategies for patients and health professionals 
through courses and training, mainly focusing on the 
quality of life of patients who complete treatment, 
with greater attention not only to presenting disabi-
lities already but also those who have not submitted 
disabilities at discharge.
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